These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30880812)

  • 1. Cannabidiol: The Need for More Information About Its Potential Benefits and Side Effects.
    Hande K
    Clin J Oncol Nurs; 2019 Apr; 23(2):131-134. PubMed ID: 30880812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol in Anxiety and Sleep: A Large Case Series.
    Shannon S; Lewis N; Lee H; Hughes S
    Perm J; 2019; 23():18-041. PubMed ID: 30624194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids and Mental Health, Part 2: The Search for Clinical Applications.
    Penn A
    J Psychosoc Nurs Ment Health Serv; 2019 Oct; 57(10):7-11. PubMed ID: 31573659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.
    Shannon S; Opila-Lehman J
    Perm J; 2016; 20(4):16-005. PubMed ID: 27768570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence.
    Boyaji S; Merkow J; Elman RNM; Kaye AD; Yong RJ; Urman RD
    Curr Pain Headache Rep; 2020 Jan; 24(2):4. PubMed ID: 31980957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products.
    Li J; Carvajal R; Bruner L; Kaminski NE
    Food Chem Toxicol; 2021 Nov; 157():112600. PubMed ID: 34626752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Hemp oil, CBD, and Marijuana Primer: Powerful Pain, Insomnia, and Anxiety-relieving Tools!
    Teitelbaum J
    Altern Ther Health Med; 2019 Jun; 25(S2):21-23. PubMed ID: 31202200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
    Crippa JA; Guimarães FS; Campos AC; Zuardi AW
    Front Immunol; 2018; 9():2009. PubMed ID: 30298064
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
    Zlebnik NE; Cheer JF
    Annu Rev Neurosci; 2016 Jul; 39():1-17. PubMed ID: 27023732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol: a potential treatment for post Ebola syndrome?
    Reznik SE; Gardner EL; Ashby CR
    Int J Infect Dis; 2016 Nov; 52():74-76. PubMed ID: 27686726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for cannabidiol in psychiatry?
    Khoury JM; Neves MCLD; Roque MAV; Queiroz DAB; Corrêa de Freitas AA; de Fátima Â; Moreira FA; Garcia FD
    World J Biol Psychiatry; 2019 Feb; 20(2):101-116. PubMed ID: 28112021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    Elsaid S; Kloiber S; Le Foll B
    Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?
    Crippa JAS; Hallak JEC; Zuardi AW; Guimarães FS; Tumas V; Dos Santos RG
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):121-133. PubMed ID: 30706171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open label evaluation of cannabidiol in dystonic movement disorders.
    Consroe P; Sandyk R; Snider SR
    Int J Neurosci; 1986 Nov; 30(4):277-82. PubMed ID: 3793381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation.
    Yu CHJ; Rupasinghe HPV
    Res Vet Sci; 2021 Nov; 140():38-46. PubMed ID: 34391060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.
    Zuardi AW; Shirakawa I; Finkelfarb E; Karniol IG
    Psychopharmacology (Berl); 1982; 76(3):245-50. PubMed ID: 6285406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological bases for a possible effect of cannabidiol in Parkinson's disease.
    Ferreira-Junior NC; Campos AC; Guimarães FS; Del-Bel E; Zimmermann PMDR; Brum Junior L; Hallak JE; Crippa JA; Zuardi AW
    Braz J Psychiatry; 2020 Apr; 42(2):218-224. PubMed ID: 31314869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
    Lorente Fernández L; Monte Boquet E; Pérez-Miralles F; Gil Gómez I; Escutia Roig M; Boscá Blasco I; Poveda Andrés JL; Casanova-Estruch B
    Neurologia; 2014 Jun; 29(5):257-60. PubMed ID: 24035293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
    White CM
    J Clin Pharmacol; 2019 Jul; 59(7):923-934. PubMed ID: 30730563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.